A global audit reveals a persistent equity gap in antenatal care for preterm births
A major international study has uncovered significant disparities in the use of two key, evidence-based antenatal interventions: magnesium sulfate (to reduce cerebral palsy risk) and corticosteroids (to prevent respiratory complications) for babies born between 24 and 32 weeks of gestation. Analyzing data from over 45,000 infants across 11 countries, researchers found that while usage is high in some high-income nations like the UK and Ireland, uptake is markedly lower in middle-income countries such as South Africa and the UAE. The disparity for magnesium sulfate is particularly stark, with no evidence of improvement over time, highlighting a critical failure in translating global clinical guidelines into equitable practice.
Why it might matter to you:
This research underscores a systemic challenge in standardizing care for high-risk pregnancies, a population that often includes individuals with diabetes. The findings directly parallel the global effort needed to standardize and improve access to preventive care for diabetic complications, such as foot care. Understanding the drivers of these international implementation gaps can inform strategies to make guideline-recommended interventions for diabetes complications more universally accessible and effective.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
